Clinical Trials Browser

INDUSTRY × Interventional × resminostat × Clear all

NCT02953301 2024-08-30

RESMAIN

Phase 2 Completed

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT02400788 2018-01-16

Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT01037478 2014-01-16

SAPHIRE

Phase 2 Completed

Hodgkin Disease